Researcher
Hannelore Ceuppens
- Keywords:Medicine
Affiliations
- Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From19 Mar 2021 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From27 Jul 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Sep 2020 → Today - Basic (bio-) Medical Sciences (Department)
Member
From1 Sep 2020 → 20 Oct 2022 - Faculty of Medicine and Pharmacy (Faculty)
Member
From10 Sep 2018 → 24 Jun 2020
Projects
1 - 1 of 1
- Backup mandate from Research Council: TITAN: imaging and manipulation of Tumor-Infiltrating T-cells using Anti-CD3 NanobodiesFrom1 Nov 2021 → 1 Nov 2021Funding: BOF - doctoral mandates
Publications
1 - 7 of 7
- In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells(2023)
Authors: Robin Maximilian Awad, Yannick De Vlaeminck, Fien Meeus, Thomas Ertveldt, Katty Zeven, Hannelore Ceuppens, Cleo Goyvaerts, Magali Verdonck, Gustavo Salguero, Geert Raes, et al.
Pages: 1-13 - Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT(2023)
Authors: Katty Zeven, Timo W M De Groof, Hannelore Ceuppens, Robin Maximilian Awad, Thomas Ertveldt, Wout de Mey, Fien Meeus, Geert Raes, Karine Breckpot, Nick Devoogdt
- Targeted α-Therapy Using 225Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment(2023)
Authors: Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, et al.
Pages: 751-758 - Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model(2022)
Authors: Thomas Ertveldt, Lien De Beck, Kirsten De Ridder, Hanne Locy, Wout de Mey, Cleo Goyvaerts, Quentin Lecocq, Hannelore Ceuppens, Yannick De Vlaeminck, Robin Maximilian Awad, et al.
Pages: 1136-1148 - Novel 3D Lung Tumor Spheroids for Oncoimmunological Assays(2022)
Authors: Kirsten De Ridder, Navpreet Tung, Jan-Timon Werle, Léa Karpf, Robin Maximilian Awad, Annie Bernier, Hannelore Ceuppens, Hélène Salmon, Cleo Goyvaerts
- Emerging applications of nanobodies in cancer therapy(2022)
Authors: Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens, Thomas Ertveldt, Heleen Hanssens, Quentin Lecocq, Lukasz Mateusiak, Katty Zeven, Hana Valenta, Timo W M De Groof, et al.
Pages: 143-199 - Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Authors: Robin Maximilian Awad, Quentin Lecocq, Katty Zeven, Thomas Ertveldt, Lien De Beck, Hannelore Ceuppens, Katrijn Broos, Yannick De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.
Pages: 172-182